Surface Oncology, Inc.

NasdaqCM:SURF Voorraadrapport

Marktkapitalisatie: US$65.1m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Surface Oncology Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Surface Oncology heeft een totaal eigen vermogen van $49.2M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $66.0M en $16.8M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsration/a
ContantUS$56.26m
AandelenUS$49.18m
Totaal verplichtingenUS$16.83m
Totaal activaUS$66.01m

Recente financiële gezondheidsupdates

Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Feb 23
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Is Surface Oncology (NASDAQ:SURF) A Risky Investment?

Nov 11
Is Surface Oncology (NASDAQ:SURF) A Risky Investment?

Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?

Jun 07
Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?

Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Feb 16
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Recent updates

Forecast: Analysts Think Surface Oncology, Inc.'s (NASDAQ:SURF) Business Prospects Have Improved Drastically

Nov 07
Forecast: Analysts Think Surface Oncology, Inc.'s (NASDAQ:SURF) Business Prospects Have Improved Drastically

Analysts Just Made A Major Revision To Their Surface Oncology, Inc. (NASDAQ:SURF) Revenue Forecasts

Aug 08
Analysts Just Made A Major Revision To Their Surface Oncology, Inc. (NASDAQ:SURF) Revenue Forecasts

Surface Oncology GAAP EPS of -$0.46 misses by $0.01

Aug 03

Surface Oncology: Neither Novartis, Nor GSK Or ARKG Is Able To Stop The Decline

May 25

News Flash: Analysts Just Made A Dazzling Upgrade To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts

May 11
News Flash: Analysts Just Made A Dazzling Upgrade To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts

Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Feb 23
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Surface Oncology: If Novartis, GlaxoSmithKline And ARK See Promise, So Do I

Jan 18

Is Surface Oncology (NASDAQ:SURF) A Risky Investment?

Nov 11
Is Surface Oncology (NASDAQ:SURF) A Risky Investment?

Surface Oncology: Staying The Course

Oct 24

Surface Oncology: A Diverse, But Early Pipeline

Jul 13

Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?

Jun 07
Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?

Surface Oncology EPS beats by $0.04, beats on revenue

May 05

Here's What Surface Oncology, Inc.'s (NASDAQ:SURF) Shareholder Ownership Structure Looks Like

Mar 15
Here's What Surface Oncology, Inc.'s (NASDAQ:SURF) Shareholder Ownership Structure Looks Like

Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Feb 16
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?

Surface Oncology: Early Stage Cancer-Specific Company With Novel Assets

Dec 09

What Kind Of Shareholders Hold The Majority In Surface Oncology, Inc.'s (NASDAQ:SURF) Shares?

Dec 08
What Kind Of Shareholders Hold The Majority In Surface Oncology, Inc.'s (NASDAQ:SURF) Shares?

Surface Oncology shares rise 13% on Fast Track tag for SRF388

Nov 11

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $60.6M ) SURF } overtreffen de korte termijn passiva ( $16.8M ).

Langlopende schulden: SURF heeft geen langlopende schulden.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: SURF is schuldenvrij.

Schuld verminderen: SURF had 5 jaar geleden geen schulden.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: SURF heeft minder dan een jaar aan cash runway op basis van de huidige vrije kasstroom.

Voorspelling contante baan: SURF heeft minder dan een jaar aan kasmiddelen als de vrije kasstroom blijft dalen met historische percentages van 15 % per jaar.


Ontdek gezonde bedrijven